Tatva Chintan Pharma Chem share price
You have to be logged in to add this to Watchlist.Tatva Chintan Pharma Chem is trading -0.12% lower at Rs 822.00 as compared to its last closing price. Tatva Chintan Pharma Chem has been trading in the price range of 850.85 & 820.00. Tatva Chintan Pharma Chem has given -48.52% in this year & -2.07% in the last 5 days.
Tatva Chintan Pharma Chem has TTM P/E ratio 139.59 as compared to the sector P/E of 21.55.There are 5 analysts who have initiated coverage on Tatva Chintan Pharma Chem. There are 2 analysts who have given it a strong buy rating & 0 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.
The company posted a net profit of -0.66 Crores in its last quarter.
Listed peers of Tatva Chintan Pharma Chem include Camlin Fine Sciences (-2.96%), Yasho Industries (-0.87%), Tatva Chintan Pharma Chem (-0.12%) etc.
Tatva Chintan Pharma Chem has a 27.98% public holding.The Mutual Fund holding in Tatva Chintan Pharma Chem was at 6.76% in 30 Sep 2024. The MF holding has increased from the last quarter. The FII holding in Tatva Chintan Pharma Chem was at 3.33% in 30 Sep 2024. The FII holding has decreased from the last quarter.
Tatva Chintan Pharma Chem share price range
|
| ||||
|
| ||||
Tatva Chintan Pharma Chem share Key Metrics
| Market Cap ( ₹ Cr.) | 1,928.91 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Tatva Chintan Pharma Chem Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 25-Oct-24 | Quarterly Results |
| 24-Jul-24 | Quarterly Results |
| 03-May-24 | Audited Results & Final Dividend |
| 20-Jan-24 | Quarterly Results |
| 02-Nov-23 | Quarterly Results |
| 04-Aug-23 | Quarterly Results |
| 11-Jul-23 | Preferential issue of shares |
| 05-May-23 | Audited Results & Final Dividend |
| 24-Jan-23 | Quarterly Results |
| 04-Nov-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 20-Sep-24 | 27-Aug-24 | AGM |
| 22-Sep-23 | 28-Aug-23 | AGM |
| 15-Aug-23 | 14-Jul-23 | POM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 03-May-24 | - | 06-Sep-24 | 2 |
| 05-May-23 | - | 08-Sep-23 | 2 |
| 25-Apr-22 | 09-Sep-22 | 08-Sep-22 | 2 |
FAQs about Tatva Chintan Pharma Chem share price
Tatva Chintan Pharma Chem is trading at 822.00 as on Mon Nov 25 2024 09:58:49. This is -0.12% lower as compared to its previous closing price of 823.00.
The market capitalization of Tatva Chintan Pharma Chem is 1928.91 Cr as on Mon Nov 25 2024 09:58:49.
The average broker rating on Tatva Chintan Pharma Chem is Hold. The breakup of analyst rating is given below -
- 2 analysts have given a strong buy rating
- 0 analysts have given a buy rating
- 0 analysts have given a hold rating
- 2 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Tatva Chintan Pharma Chem is 1647.95 whereas the 52 wk low is 789.05
Tatva Chintan Pharma Chem can be analyzed on the following key metrics -
- TTM P/E: 139.59
- Sector P/E: 21.55
- Dividend Yield: 0.24%
- D/E ratio: 0.02
Tatva Chintan Pharma Chem reported a net profit of 30.35 Cr in 2024.
Tatva Chintan Pharma Chem Quick Links
Tatva Chintan Pharma Chem Dividend Tatva Chintan Pharma Chem Bonus Tatva Chintan Pharma Chem News Tatva Chintan Pharma Chem AGM Tatva Chintan Pharma Chem Rights Tatva Chintan Pharma Chem Splits Tatva Chintan Pharma Chem Board Meetings Tatva Chintan Pharma Chem Key Metrics Tatva Chintan Pharma Chem Shareholdings Tatva Chintan Pharma Chem Profit Loss Tatva Chintan Pharma Chem Balance Sheet Tatva Chintan Pharma Chem Cashflow Tatva Chintan Pharma Chem Q1 Results Tatva Chintan Pharma Chem Q2 Results Tatva Chintan Pharma Chem Q3 Results Tatva Chintan Pharma Chem Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks